Southwestern internal medicine conference: Clinical use of hematopoietic growth factors

Pharmacology, Toxicology and Pharmaceutical Science

• Neutropenia 100%
• Hemopoietic Growth Factor 100%
• Granulocyte Colony Stimulating Factor 80%
• Granulocyte Macrophage Colony Stimulating Factor 60%
• Clinical Trial 40%
• Toxicity 40%
• Chemotherapy 20%
• Growth Factor 20%
• Blindness 20%
• Bacterium 20%
• Acquired Immune Deficiency Syndrome 20%
• Aplastic Anemia 20%
• Severe Congenital Neutropenia 20%
• Myelodysplastic Syndrome 20%
• Yeast 20%

Immunology and Microbiology

• Granulocyte Colony-Stimulating Factor 100%
• Granulocyte Macrophage Colony-Stimulating Factor 75%
• Neutrophil Count 50%
• Growth Factor 25%
• Bone Marrow Transplantation 25%
• Cyclic Neutropenia 25%
• Kostmann Syndrome 25%
• Cells 25%
• Cell Surface 25%
• Bacterium 25%
• Dose 25%
• Maturation 25%
• Yeast 25%
• Blood Level 25%
• Acquired Immune Deficiency Syndrome 25%
• Neutrophil 25%
• Aplastic Anemia 25%